Revive Therapeutics Update Following U.S. FDA Approval of Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, Aug. 05, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV,…

Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, July 31, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV),…

The race to treat COVID-19 | All eyes are on this company right now

RVV (CSE) | RVVTF (OTC) Since March 2020, we have been living through one of the…

Why M2Bio Sciences | WUHN is a stock to watch ?

M2Bio Sciences, Inc | WUHN on OTC (Formely Wuhan General Group) For several weeks now, a…

Psychedelic highlights | july 20-24

The Cannabis Stock brings you the major news from the last week in the psychedelic market.…

M2Bio Sciences, Inc (Wuhan General Group) Signs MOA for the Acquisition of Tsime Pharmaceuticals (PTY) Limited

M2Bio Sciences, Inc | WUHN on OTC (Formely Wuhan General Group) CAPE TOWN, SA / ACCESSWIRE…

M2Bio Sciences inc, an opportunity of a lifetime?

M2Bio Sciences, Inc | WUHN on OTC (Formely Wuhan General Group) In a stock market that…

Wuhan General Group Signs Manufacturing, Distribution and Sales Agreement with Cafféluxe for local and international distribution of Medspresso™

WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) VISIT WUHN PROFILE HERE MONTREAL, QC / ACCESSWIRE / June…

Wuhan General Group Announces Name Change and Rebranding to M2Bio Sciences

M2Bio Sciences, Inc | MMBS MONTREAL, QC / ACCESSWIRE / June 18, 2020 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN)…

Revive Therapeutics Expands Research Partnership for Novel Formulation Development and Clinical Research of Psilocybin with the University of Wisconsin-Madison

TORONTO, June 12, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV),…

The psychedelic market | A little-known and undervalued company ahead of their peers

LAST ALERT MADE MORE THAN 800% ! This article is written and published by The Cannabis Stock…

Revive Therapeutics Provides Update on Discussions with Health Canada in Pre-CTA Meeting

TORONTO, June 09, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV),…